Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 281 participants.
Also called NCT06415214
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 281 participants
- Registry
-
NCT06415214
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06415214. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-21 (actual); primary completion 2025-07-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes
- Acronym
- SOLID-DKD
- Condition
- Diabetic Kidney Disease, Type 2 Diabetes
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- HRS-7535
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct06415214- Content hash
b524dde14bd5580dded641fd3f31be8ad26bda663f3b6d8520396a264f3cabef